technology [42].
Regulatory and Reimbursement Issues
The reimbursement framework for AI/ML technologies within healthcare is evolving, presenting limited
opportunities for direct reimbursement. Challenges arise due to the conventional emphasis on clinicians as
the primary providers of healthcare services, which can impede the integration of AI/ML technologies into
routine healthcare practices [43]. Regulatory compliance is a critical aspect governed by the FDA in
overseeing AI/ML technologies intended for healthcare use. The FDA's scope of oversight concerning AI/ML
software is expanding, with an increasing number of devices incorporating AI/ML functionalities undergoing